Specification
Side by side
| Cartalax | Epithalon | |
|---|---|---|
| Class | Synthetic tetrapeptide | |
| Residues | 4 | |
| Sizes | 20 mg | 10 mg |
Origin and target
Where each one comes from, and what it binds
Cartalax
Origin. A short synthetic peptide from the Khavinson bioregulator series.
Target. Characterised structurally; no defined receptor is established in the literature.
Full referenceEpithalon
Origin. The tetrapeptide alanyl-glutamyl-aspartyl-glycine, from the Khavinson short-peptide series.
Target. A four-residue sequence characterized by its composition rather than a named receptor.
Full referenceRead next
Each one on its own page
Handling
The same for both
Both ship as freeze-dried powder, both mix with bacteriostatic water the same way, and both are stored at minus 20 C out of the light until then. What differs is which breakdown route each sequence is prone to, and the stability guide shows how to read that from the amino acids.
Documentation
Both tested, both certificates published
Whichever you order, the latest lab certificate is on its product page.